DIN 02564564 — APO-CANAGLIFLOZIN 300 MG
APO-CANAGLIFLOZIN is a tablet of Canagliflozin marketed by APOTEX INC. The full Canagliflozin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02564564
- Brand name
- APO-CANAGLIFLOZIN
- Active ingredient
- Canagliflozin
- Strength
- 300 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- Sodium-glucose co-transporter 2 (SGLT2) inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Canagliflozin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02564556 | APO-CANAGLIFLOZIN | 100 MG | TABLET | APOTEX INC | MARKETED |
| 02510367 | AURO-CANAGLIFLOZIN | 100 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02510375 | AURO-CANAGLIFLOZIN | 300 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02425483 | INVOKANA | 100 MG | TABLET | JANSSEN INC | MARKETED |
| 02425491 | INVOKANA | 300 MG | TABLET | JANSSEN INC | MARKETED |
| 02543486 | JAMP CANAGLIFLOZIN | 100 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02543494 | JAMP CANAGLIFLOZIN | 300 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |